Tenet Healthcare Corporation (THC)
Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Will Lower Patient Days Affect Tenet Healthcare's Q3 Earnings?
THC's third-quarter results may show profit growth despite lower patient days and mixed hospital trends.
Tenet Healthcare: USPI Momentum Expected To Sustain Q3 Earnings, Why I Choose To Buy
Tenet Healthcare is rated BUY, driven by its strategic shift to high-margin outpatient care and strong growth in its USPI division. THC benefits from policy tailwinds, expanding outpatient-eligible procedures, and attractive valuation with a forward EV/EBITDA of 7.33, well below industry peers. Key risks include heavy reliance on Medicare/Medicaid, ongoing litigation at St. Vincent Hospital, and operational leverage, though these appear over-reflected in the current valuation.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Most-Watched Stock Tenet Healthcare Corporation (THC) Worth Betting on Now?
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
Tenet Healthcare (THC) closed at $191.78 in the latest trading session, marking a -2.35% move from the prior day.
Tenet (THC) Up 14.9% Since Last Earnings Report: Can It Continue?
Tenet (THC) reported earnings 30 days ago. What's next for the stock?
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Should You Invest in Tenet (THC) Based on Bullish Wall Street Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
